Drug repurposing and cytokine management in response to COVID-19: A review

Coronavirus disease 2019 (COVID-19), the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease that attacks the respiratory tract and has a higher fatality rate than seasonal influenza. The COVID‐19 pandemic is a global health crisis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Heimfarth, Luana, Serafini, Mairim Russo, Martins-Filho, Paulo Ricardo, Quintans, Jullyana de Souza Siqueira, Quintans-Júnior, Lucindo José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457938/
https://www.ncbi.nlm.nih.gov/pubmed/32919216
http://dx.doi.org/10.1016/j.intimp.2020.106947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457938/
https://www.ncbi.nlm.nih.gov/pubmed/32919216
http://dx.doi.org/10.1016/j.intimp.2020.106947

Ejemplares similares